Acting out of ethics: what the open letter asks.
Lunstroth
John
J
Mailman School of Public Health, Columbia University.
D001802:Blood Substitutes; D003159:Community-Institutional Relations; D030881:Disclosure / Q000941:ethics; D004345:Drug Industry / Q000941:ethics; D004636:Emergency Service, Hospital / Q000941:ethics*; D004638:Emergency Treatment / Q000941:ethics*; D028744:Ethics Committees, Research; D032984:Ethics, Research; D006454:Hemoglobins / Q000627:therapeutic use; D006801:Humans; D016365:Liability, Legal; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*; D015871:Scientific Misconduct; D014481:United States; D014486:United States Food and Drug Administration
D001802:Blood Substitutes; D006454:Hemoglobins; C509893:PolyHeme